Nuclear Medicine and Biology
Volume 33, Issue 1 , Pages 15-19, January 2006

Synthesis and in vivo evaluation of a PET radioligand for imaging the endothelin-A receptor

  • William B. Mathews

      Affiliations

    • Department of Radiology, Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 410 614 0110; fax: +1 410 614 0111.
  • ,
  • Tamas G. Zober

      Affiliations

    • Department of Radiology, Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
  • ,
  • Hayden T. Ravert

      Affiliations

    • Department of Radiology, Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
  • ,
  • Ursula Scheffel

      Affiliations

    • Department of Radiology, Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
  • ,
  • John Hilton

      Affiliations

    • Department of Radiology, Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
  • ,
  • Darryl Sleep

      Affiliations

    • Abbott Laboratories, Abbott Park, IL 60064, USA
  • ,
  • Robert F. Dannals

      Affiliations

    • Department of Radiology, Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
  • ,
  • Zsolt Szabo

      Affiliations

    • Department of Radiology, Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA

Received 7 February 2005; received in revised form 27 July 2005; accepted 29 July 2005.

Abstract 

The endothelin-A receptor ligand Atrasentan (ABT-627) was radiolabeled by 11C-methylaton of the desmethyl precursor in phenolate form. In mice, the highest uptake of [11C]ABT-627 was in the liver, kidneys and lungs. No significant binding was observed in mouse brain or heart. PET studies in a baboon, however, showed accumulation in the myocardium and lungs with a tissue/blood equilibrium reached at 40 min postinjection. Between 35 and 75 min, the heart/blood and lung/blood ratios were 1.72 and 1.31, respectively. Pretreatment with a 0.39 mg/kg dose of unlabeled ABT-627 inhibited the uptake of the tracer by 53–54% in both the myocardium and lungs at 65 min.

Keywords: Atrasentan, ABT-627, Baboon, Endothelin, PET

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0969-8051(05)00201-5

doi:10.1016/j.nucmedbio.2005.07.012

Nuclear Medicine and Biology
Volume 33, Issue 1 , Pages 15-19, January 2006